4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid ethyl ester
![BK7D52 | 330785-83-6 | 4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid ethyl ester](https://qncdn.chemcd.cn/alchemypharm/330785-83-6.png "BK7D52 | 330785-83-6 | 4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid ethyl ester")
Catalog No.: BK7D52
CAS.RN：330785-83-6
Molecular Formula: C20H25ClN4O4
Molecular Weight: 420.89 g/mol
Purity: NLT 98%
Intermediates of Avanafil
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA23C3 | Avanafil API | 330784-47-9 |
| BK0S6Q | 2-aMinomethylpyrimidine Hydrochloride | 372118-67-7 |
| BK31MB | Ethyl 4-chloro-2-methylthio-5-pyrimidinecarboxylate | 5909-24-0 |
| BK3SR1 | 3-Chloro-4-methoxybenzylamine hydrochloride | 41965-95-1 |
| BK61M7 | 4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-(methylthio)-5-pyrimidinecarboxylic acid ethyl ester | 330785-81-4 |
| BK7D52 | 4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid ethyl ester | 330785-83-6 |
| BK9XB6 | 4-[[(3-Chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-5-pyrimidinecarboxylic acid | 330785-84-7 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
